000 01514 a2200433 4500
005 20250516122945.0
264 0 _c20131104
008 201311s 0 0 eng d
022 _a1476-5438
024 7 _a10.1038/ejhg.2012.261
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCastellanos, Elisabeth
245 0 0 _aIn vitro antisense therapeutics for a deep intronic mutation causing Neurofibromatosis type 2.
_h[electronic resource]
260 _bEuropean journal of human genetics : EJHG
_cJul 2013
300 _a769-73 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aCells, Cultured
650 0 4 _aFibroblasts
_xcytology
650 0 4 _aGerm-Line Mutation
_xgenetics
650 0 4 _aHumans
650 0 4 _aIntrons
_xgenetics
650 0 4 _aMorpholinos
_xadministration & dosage
650 0 4 _aNeurofibromatosis 2
_xgenetics
650 0 4 _aNeurofibromin 2
_xgenetics
650 0 4 _aRNA, Antisense
_xgenetics
700 1 _aRosas, Imma
700 1 _aSolanes, Ares
700 1 _aBielsa, Isabel
700 1 _aLázaro, Conxi
700 1 _aCarrato, Cristina
700 1 _aHostalot, Cristina
700 1 _aPrades, Pepe
700 1 _aRoca-Ribas, Francesc
700 1 _aBlanco, Ignacio
700 1 _aSerra, Eduard
773 0 _tEuropean journal of human genetics : EJHG
_gvol. 21
_gno. 7
_gp. 769-73
856 4 0 _uhttps://doi.org/10.1038/ejhg.2012.261
_zAvailable from publisher's website
999 _c22297852
_d22297852